Thermo Fisher Scientific (TMO) Treasury Shares (2009 - 2026)

Thermo Fisher Scientific has disclosed Treasury Shares across 18 years of filings, most recently posting $25.4 billion for Q1 2026.

• Quarterly Treasury Shares rose 19.23% year-over-year to $25.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.4 billion (up 19.23% YoY) and the FY2025 annual result came in at $22.3 billion, up 16.04% from the prior year.
• Treasury Shares grew to $25.4 billion in Q1 2026, from $22.3 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $73.9 million in Q1 2026 and troughed at $48.0 million in Q2 2022.
• A 5-year average of $59.3 million and a median of $61.0 million in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares soared 37.61% — and 2025, when it rose 16.04%.
• Tracing TMO's Treasury Shares over 5 years: stood at $12.0 billion in 2022, then grew by 25.93% to $15.1 billion in 2023, then grew by 27.05% to $19.2 billion in 2024, then grew by 16.04% to $22.3 billion in 2025, then increased by 13.68% to $25.4 billion in 2026.
• Business Quant data shows TMO's Treasury Shares at $25.4 billion in Q1 2026, $22.3 billion in Q4 2025, and $22.3 billion in Q3 2025.